These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The implication of background anthracosis in the development and progression of pulmonary adenocarcinoma. Wang D, Minami Y, Shu Y, Konno S, Iijima T, Morishita Y, Noguchi M. Cancer Sci; 2003 Aug; 94(8):707-11. PubMed ID: 12901796 [Abstract] [Full Text] [Related]
24. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T. Cancer Res; 1992 May 01; 52(9):2478-81. PubMed ID: 1314694 [Abstract] [Full Text] [Related]
26. Topographical distributions of allelic loss in individual non-small-cell lung cancers. Yatabe Y, Konishi H, Mitsudomi T, Nakamura S, Takahashi T. Am J Pathol; 2000 Sep 01; 157(3):985-93. PubMed ID: 10980137 [Abstract] [Full Text] [Related]
27. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Devereux TR, Holliday W, Anna C, Ress N, Roycroft J, Sills RC. Carcinogenesis; 2002 Oct 01; 23(10):1737-43. PubMed ID: 12376484 [Abstract] [Full Text] [Related]
28. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. Cancer Res; 2000 Apr 01; 60(7):1949-60. PubMed ID: 10766185 [Abstract] [Full Text] [Related]
29. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Miyai K, Furugen Y, Matsumoto T, Iwabuchi K, Hirose S, Kinoshita K, Fujii H. Gynecol Oncol; 2004 Jul 01; 94(1):115-20. PubMed ID: 15262128 [Abstract] [Full Text] [Related]
30. Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma. Matsumoto S, Iwakawa R, Kohno T, Suzuki K, Matsuno Y, Yamamoto S, Noguchi M, Shimizu E, Yokota J. Int J Cancer; 2006 May 15; 118(10):2498-504. PubMed ID: 16353158 [Abstract] [Full Text] [Related]
33. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB, Amare Kadam PS. Urol Oncol; 2013 Oct 15; 31(7):1333-42. PubMed ID: 21962529 [Abstract] [Full Text] [Related]
34. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung]. Shao S, Sun W, Zhang J, An Q, Xiao T, Yang P, Cheng S, Gao Y. Zhonghua Yi Xue Za Zhi; 2002 Jun 10; 82(11):740-2. PubMed ID: 12126542 [Abstract] [Full Text] [Related]
37. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E. Cancer Res; 1991 Jun 01; 51(11):2926-31. PubMed ID: 2032230 [Abstract] [Full Text] [Related]
39. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach. Nishizuka S, Tamura G, Terashima M, Satodate R. J Pathol; 1998 May 01; 185(1):38-43. PubMed ID: 9713358 [Abstract] [Full Text] [Related]